Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,639 public trials 336 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

NCT06149286

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States
  • Indiana University and Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Hattiesburg Clinic Hattiesburg, Mississippi, United States
View all 171 locations
View Trial Details
Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
  • IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
  • Hospital Beata Maria Ana Madrid, Spain
  • Hospital Fundación Jiménez Diaz Madrid, Spain
View all 17 locations
View Trial Details
Recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

NCT06287229

Conditions
B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

NCT06533579

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details

Related conditions